Moxifloxacin vs Tositumomab
Moxifloxacin vs Tositumomab: Overview
This comparison examines the pharmacological differences between Moxifloxacin and Tositumomab.
Mechanism of Action
Moxifloxacin: Fourth-generation fluoroquinolone inhibiting DNA gyrase and topoisomerase IV with enhanced anaerobic activity.
Pharmacokinetics
Half-life: Moxifloxacin β 12 hours.
Chemical Properties
Molecular Formula: Moxifloxacin β C21H24FN3O4.
Molecular Weight: Moxifloxacin β 401.4350 g/mol.
Type: Moxifloxacin β Small molecule; Tositumomab β Antibody.